Products Finishing, market information

Exposure to endosulfan residues in tobacco products could be another important source of general population exposure. Endosulfan residues in tobacco leaves and finished tobacco products were reviewed by EPA (1982a). Eor example, auction market tobacco had a mean residue of <0.2-14 ppm endosulfan and endosulfan sulfate in the early 1970s, and cigarettes sold in 1973 contained a mean residue of 0.83 ppm endosulfan. No information was found in the available literature regarding endosulfan concentrations in cigarette smoke. 

Food additives (like color additives) can be added at various processing stages, but the additions are commonly made at the latest production stage before final marketing to ensure optimal functionality of the additive in the product as sold. Residues of additives used at earlier production stages may be present still in the final formulation. However, if they do not have further functions at that stage, they are considered process aids (to help preparation but without technological effects in the finished product) and are not indicated on labels. Some additives also decompose over time so that the levels present at the end of shelf life may be quite low. Several techniques and information sources can be used to assess contamination levels of chemicals ... 

Polybrominated Diphenyl Ethers. Information on the relative importance of different routes of exposure to PBDEs is limited. Data on the concentrations of PBDEs in foods, collected using a market-basket approach, are needed to determine concentrations of PBDEs in foods consumed by the general population. Data on the PBDE concentrations in foods grown in contaminated areas, particularly in the vicinity of hazardous waste sites, are also needed. Data on congener-specific PBDE analysis of food, especially plant products, would be useful. More monitoring data on the concentrations of total PBDEs as well as conquers in air in remote, rural, urban, and areas near hazardous waste sites and incinerators are needed. Data on PBDE concentrations in finished drinking water nationwide would be helpful. 

Medical Information supporting products released to market can exist in many different formats. The medical information produced for the finished product, whether in label format or as a package insert, should correspond with the actual ingredients that the product is formulated to contain and the method and dosage that corresponds with its license. 

Stability studies on a finished pharmaceutical product should be designed in the light of the properties and stability characteristics of the drug substance as well as the climatic conditions of the intended market zone. Before stability studies of dosage forms are initiated, information on the stability of the drug substance should be sought, collected and analyzed. Published information on stability is available on many well-established drug substances. 

A 510(k) is a term commonly used to refer to a pre-market application sent to the FDA. The information in this application documents the safety and efficacy of the finished medical device. If the FDA deems the device to be substantially equivalent to an adequate legally marketed medical device that is currently approved for marketing in the United States, clearance is granted to market the product. Visit www.fda.gov/cdrh/510khome.html for more information. 

Very often the market demand and the price of the finished products that the supply chain provides are uncertain. Even for a strategic alliance supply chain which has a dominant core business, what it can coordinate and control is only limited to the supply and demand, price and other related information between node enterprises inside the supply chain. In the face of rapidly changing external market, it is difficult to determine parameters like the quantity of demand and price exactly. But decision makers can derive a probability distribution ffinction of the changing within the market demand and the price of the product through the analysis of the historical data of demand and price. In other words, we can use random variables to describe such uncertain parameters as demand quantity and price. 

Strategic alliance supply chain can coordinate and control the supply, demand, price and other information of the node enterprises in the supply chain. However, decentralized control supply chain cannot do that. Therefore, for every node enterprise in the decentralized control supply chain, it is hard to accurately acquire the market supply price information of raw materials and market demand price information of finished products. The decision-maker of the enterprises can nevertheless obtain the probability distribution function of the changes of the market prices of raw materials and finished products by analyzing the purchasing prices, sale prices and other historical data. That is to say, two uncertain parameters— market supply price of raw materials and market demand price of finished products can be described by random variables. 

Thus, data, information and knowledge on the purchase market suppliers, product structure and design the subjects of flow (raw materials, production materials, work-in-progress, finished products, packaging, returns, waste and residual products) the sales market and end-consumers are aU transferred in supply chains. This means that there are multiple soiuces of data. Information and knowledge. These sources are presented in Table 6.1, taking into accoimt the internal and external sources, divided into primary and secondary somces. 

---